Molecular and Phenotypic Characteristics of Staphylococcus Hominis Isolates From Pediatric Infections

Document Type: Short Communication


1 Associate Professor, Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, and Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Associate Professor, Zoonosis Research Center, Tehran University of Medical Sciences, and Department of Medical Laboratory Sciences, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


Background: Staphylococcus hominis has been recently emerged as an opportunistic hospital-associated pathogen. The aim of this study was to characterize the antimicrobial susceptibility pattern, biofilm formation, and staphylococcal cassette chromosome mec (SCCmec) types among clinical isolates of S. hominis obtained from pediatric infections. Methods: Totally, twenty- two clinically significant S. hominis isolates, mostly from blood samples, were examined for antibiotic resistance, SCCmec typing, and biofilm formation.  Results: Multiresistance was observed in 86 % of isolates. Among mecA positive isolates (77%), SCCmec type I (28%), III (22%), IV (22%), and non-typeable ones (28%) were detected. More than half of the isolates (54.5%) did not produce biofilm. No significant association was found between biofilm formation and the presence of ica operon. Conclusion: As S. hominis isolates were not strong biofilm producers, biofilm formation cannot be considered as much as important multidrug the pathogenesis of isolates.


  1. Aghazadeh M, Ghotaslou R, Ahangarzadeh Rezaee M, Moshafi MH, Hojabri Z, Saffari F. Determination of antimicrobial resistance profile and inducible clindamycin resistance of coagulase negative staphylococci in pediatric patients: the first report from Iran. World J Pediatr 2015; 11(3):250-4.
  2. Chaves F, García-Álvarez M, Sanz F, Alba C, Otero JR. Nosocomial spread of a Staphylococcus hominis subsp. novobiosepticus strain causing sepsis in a neonatal intensive care unit. J Clin Microbial 2005; 43(9):4877-9.
  3. Mendoza-Olazarán S, Morfín-Otero R, Villarreal-Treviño L, Rodríguez-Noriega E, Llaca-Díaz J, Camacho-Ortiz A, et al. Antibiotic Susceptibility of Biofilm Cells and Molecular Characterization of Staphylococcus hominis Isolates from Blood. PloS One 2015; 10(12):e0144684.
  4. Szczuka E, Makowska N, Bosacka K, Słotwińska A, Kaznowski A. Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens. Folia Microbiol (Praha) 2015; 60(2):1-5.
  5. Petinaki E, Spiliopoulou I, Maniati M, Maniatis AN. Emergence of Staphylococcus hominis strains expressing low-level resistance to quinupristin /dalfopristin in Greece. J Antimicrob Chemother 2005; 55(5):811-2.
  6. Ruiz de Gopegui E, Iuliana Marinescu C, Díaz P, Socías A, Garau M, Ayestarán JI, et al. Nosocomial spread of linezolid-resistant Staphylococcus hominis in two hospitals in Majorca. Enferm Infect Micobiol Clin 2011; 29(5):339-44. [In Spanish].
  7. Ghotaslou R, Aghazadeh M, Ahangarzadeh Rezaee M, Moshafi MH, Forootanfar H, Hojabri Z, et al. The prevalence of aminoglycoside-modifying enzymes among coagulase negative staphylococci in Iranian pediatric patients. J Infect Chemother 2014; 20(9):569-73.
  8. Mendoza-Olazarán S, Morfin-Otero R, Rodríguez-Noriega E, Llaca-Díaz J, Flores-Treviño S, González-González GM, et al. Microbiological and molecular characterization of Staphylococcus hominis isolates from blood. PloS One 2013; 8(4):e61161.
  9. De Silva GD, Kantzanou M, Justice A, Massey RC, Wilkinson AR, Day NP, et al. The ica operon and biofilm production in coagulase- negative staphylococci associated with carriage and disease in a neonatal care unit. J Clin Microbiol 2002; 40(2):382-88.
  10. De Allori MC, Jure MA, Romero C, de Castillo ME. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol Pharm Bull 2006; 29(8):1592-6.
  11. Garza-González E, Morfin-Otero R, Martínez-Vázquez MA, Gonzalez-Diaz E, González-Santiago O, Rodríguez-Noriega E. Microbiological and molecular characterization of human clinical isolates of Staphylococcus cohnii, Staphylococcus hominis, and Staphylococcus sciuri. Scand J Infect Dis 2011; 43(11-12):930-6.
  12. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG. Hospital Epidemiology and Infection Control. 4th ed. Philadelphia: Willians & Wilkins; 2011. p. 1695-702.
  13. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late- onset sepsis in very low birth weight Neonates: the experience of the NICHD neonatal research network. Pediatrics 2002; 110(2 Pt 1):285-91.
  14. Szabados F, Woloszyn J, Richter C, Kaase M, Gatermann S. Identification of molecularly defined Staphylococcus aureus strains using matrix-assisted laser desorption/ionization time of flight mass spectrometry and the Biotyper 2.0 database. J Med Microbiol 2010; 59(Pt 7):787-90.
  15. Clinical and Laboratory Standards Institute. January 2015M100-S25Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. [cited 2019 Nov 17] Available from:
  16. Saffari F, Widerström M, Gurram BK, Edebro H, Hojabri Z, Monsen T. Molecular and Phenotypic Characterization of Multidrug-Resistant Clones of Staphylococcus epidermidis in Iranian Hospitals: Clonal Relatedness to Healthcare-Associated Methicillin-Resistant Isolates in Northern Europe. Microb Drug Resist 2016; 22(7):570-7.
  17. Shahriar M, Haque MR, Kabir S, Dewan I, Bhuyian MA. Effect of proteinase-K on genomic DNA extraction from gram-positive strains. Stamford J Pharma Sci 2011; 4(1):53-7.
  18. Boye K, Bartels MD, Andersen IS, Moeller JA, Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect 2007; 13(7):725-7.
  19. Zhang L, Thomas JC, Miragaia M, Bouchami O, Chaves F, d'Azevedo PA, et al. Multilocus sequence typing and further genetic characterization of the enigmatic pathogen, Staphylococcus hominis. PLoS One 2013; 8(6):e66496.
  20. Bouchami O, Ben Hassen A, de Lencastre H, Miragaia M. Molecular epidemiology of methicillin-resistant Staphylococcus hominis (MRSHo): low clonality and reservoirs of SCCmec. Structural elements. PLoS One 2011; 6(7):e21940.